Arild Christian Rustan

Arild Christian Rustan is a Professor in the Section for Pharmacology and Pharmaceutical Biosciences at the University of Oslo's Department of Pharmacy. His research focuses on energy metabolism, mitochondrial function, metabolic switching, and insulin resistance in human skeletal muscle cells (myotubes) derived from normal, obese, or type 2 diabetic individuals. He teaches physiology, basic pharmacology, and pharmacotherapy across multiple courses in the 5-year master's degree program in pharmacy.

Professor Rustan's research interests center on cellular metabolic regulation, with particular expertise in how skeletal muscle cells handle energy substrates under various physiological and pathological conditions. His work examines the effects of different fatty acids, exercise models, and metabolic stressors on cellular energy utilization, with significant implications for understanding obesity, type 2 diabetes, and other metabolic disorders. He employs primary human cell culture models to investigate the molecular mechanisms underlying metabolic diseases.

Analysis of Professor Rustan's recent publications reveals a consistent focus on metabolic regulation in skeletal muscle cells, with particular attention to lipid metabolism, glucose handling, and insulin signaling pathways. His research frequently explores how different nutrient conditions, genetic modifications, and disease states affect cellular energy utilization and metabolic flexibility.

Professor Rustan has been actively involved in multiple collaborative research initiatives, including EU projects such as Lipgene Nutrigenomics (NuGo) and Mitoeagle (COST-action CA15203). He served as the Norwegian coordinator for the Polish-Norwegian Research Fund (OPI-EAA) and was a Management Committee member of MITOFOOD (COST-action FA0602).

He leads the research group 'Energy Metabolism in Health and Disease (MetHealth)' which investigates fundamental aspects of cellular energy metabolism and its dysregulation in disease states. His laboratory employs various cellular models, particularly human skeletal muscle cells, to study metabolic pathways and their responses to different physiological and pathological conditions, with ongoing research spanning from basic mechanisms to potential therapeutic applications.